Omeros Corporation (OMER)

12:20 PM

What analysts say about Omeros Corporation stockExceptional profit potential - Autocar Professional

12:20 PM

Jul 23, 2025

Omeros Corporation Stock Analysis and ForecastPhenomenal trading returns - jammulinksnews.com

Jul 23, 2025

Jul 23, 2025

What drives Omeros Corporation stock priceStrongest growth potential - jammulinksnews.com

Jul 23, 2025

Jul 22, 2025

Why Omeros Corporation stock attracts strong analyst attentionAnalyst Grade Signals - Newser

Jul 22, 2025

Jul 20, 2025

Is Omeros Corporation a good long term investmentSky-high profits - PrintWeekIndia

Jul 20, 2025

Jul 19, 2025

How Omeros Corporation stock performs during market volatilityStrategic High Profit Opportunities - beatles.ru

Jul 19, 2025

Jul 17, 2025

what makes omeros corporation stock price move sharplyFree Access to Community - Newser

Jul 17, 2025

Jul 16, 2025

FY2027 Earnings Forecast for Omeros Issued By HC Wainwright - Defense World

Jul 16, 2025

Jul 15, 2025

What makes Omeros Corporation stock price move sharplyWatchlist Winner Update - Newser

Jul 15, 2025

Jul 11, 2025

Omeros Corporation (NASDAQ:OMER) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World

Jul 11, 2025

Jul 07, 2025

Omeros gets FDA acceptance for narsoplimab BLA resubmission - MSN

Jul 07, 2025

Jul 05, 2025

Wealth Enhancement Advisory Services LLC Takes $579,000 Position in Omeros Corporation (NASDAQ:OMER) - Defense World

Jul 05, 2025

Jul 04, 2025

Omeros Seeks EMA Approval For Narsoplimab After Data Shows 3X Survival Boost - MSN

Jul 04, 2025

Jul 03, 2025

Both retail investors who control a good portion of Omeros Corporation (NASDAQ:OMER) along with institutions must be dismayed after last week's 12% decrease - simplywall.st

Jul 03, 2025

Jul 02, 2025

Omeros shareholders elect directors and approve executive pay at annual meeting - Investing.com

Jul 02, 2025

Jun 30, 2025

Omeros stock maintains Buy rating at H.C. Wainwright on EU submission - Investing.com

Jun 30, 2025

Jun 28, 2025

Omeros (NASDAQ:OMER) Downgraded by Wall Street Zen to “Sell” - Defense World

Jun 28, 2025

Jun 27, 2025

Omeros' Narsoplimab: A Lifeline for TA-TMA Patients and a Regulatory Crossroads - AInvest

Jun 27, 2025

Jun 27, 2025

Omeros Submits Narsoplimab Marketing Authorization Application to the European Medicines Agency for the Treatment of TA-TMA | OMER Stock News - GuruFocus

Jun 27, 2025

Jun 27, 2025

Omeros (OMER) Eyes European Approval for Key Drug Narsoplimab | OMER Stock News - GuruFocus

Jun 27, 2025

Jun 24, 2025

Omeros Announces Webcast Details for Annual Meeting of Shareholders - FinancialContent

Jun 24, 2025

Jun 16, 2025

Ratios Revealed: Decoding Omeros Corporation (OMER)’s Financial Health - DWinneX

Jun 16, 2025

Jun 16, 2025

Omeros Co. (NASDAQ:OMER) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World

Jun 16, 2025

Jun 13, 2025

What is HC Wainwright’s Forecast for Omeros FY2025 Earnings? - Defense World

Jun 13, 2025

Jun 12, 2025

HC Wainwright Predicts Omeros’ Q2 Earnings (NASDAQ:OMER) - Defense World

Jun 12, 2025

Jun 11, 2025

Omeros (NASDAQ:OMER) Now Covered by Analysts at HC Wainwright - Defense World

Jun 11, 2025

Jun 11, 2025

Cantor Fitzgerald Comments on Omeros FY2026 Earnings - Defense World

Jun 11, 2025

Jun 10, 2025

Omeros Analyst Sees $1 Billion Potential For Narsoplimab Before FDA Decision - Benzinga

Jun 10, 2025

Jun 10, 2025

Trend Tracker for (OMER) - news.stocktradersdaily.com

Jun 10, 2025

Jun 10, 2025

Omeros (OMER) Receives Buy Rating from HC Wainwright & Co. | OME - GuruFocus

Jun 10, 2025

Jun 10, 2025

Omeros (OMER) Receives Buy Rating from HC Wainwright & Co. | OMER Stock News - GuruFocus

Jun 10, 2025

Jun 10, 2025

HC Wainwright Initiates Coverage on Omeros With Buy Rating, $9 Price Target - MarketScreener

Jun 10, 2025

Jun 10, 2025

Omeros (OMER) Set for Growth with Potential Narsoplimab Approval - GuruFocus

Jun 10, 2025

Jun 10, 2025

Omeros (OMER) Set for Growth with Potential Narsoplimab Approval | OMER Stock News - GuruFocus

Jun 10, 2025